1.46 USD
↘ 0.00 (0.07%)LIVE (AS OF 02:24 PM EST)
Kalaris Therapeutics, Inc. Common Stock (KLRS) trades at $1.46 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Nov 16, 2026.